(Q38404913)

2 September 2017

title

Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues (English)

1 reference

2 September 2017

1 reference

4

Daniela Berg

1 reference

2 September 2017

2

Katharina Malinowsky

1 reference

2 September 2017

Claudia Schuster

1

1 reference

2 September 2017

Sibylle Liebmann

3

1 reference

2 September 2017

Claudia Wolff

5

1 reference

2 September 2017

Kai Tran

6

1 reference

2 September 2017

Christina Schott

7

1 reference

2 September 2017

Simone Reu

8

1 reference

2 September 2017

Jens Neumann

9

1 reference

2 September 2017

Claudius Faber

10

1 reference

2 September 2017

Heinz Höfler

11

1 reference

2 September 2017

Thomas Kirchner

12

1 reference

2 September 2017

Karl-Friedrich Becker

13

1 reference

2 September 2017

Falk Hlubek

14

1 reference

2 September 2017

language of work or name

1 reference

6 March 2012

1 reference

2 September 2017

1 reference

2 September 2017

volume

60

1 reference

2 September 2017

issue

6B

1 reference

2 September 2017

page(s)

E37-50

1 reference

Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Future of personalized medicine in oncology: a systems biology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

The cancer biomarker problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Enabling personalized cancer medicine through analysis of gene-expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

The molecular pathology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Analytic variability in immunohistochemistry biomarker studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Targeted therapies for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

How reliable are G-protein-coupled receptor antibodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Epitope mapping of antibodies using bacterial surface display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Lack of specificity of commercially available antisera: better specifications needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Lack of specificity of antibodies directed against human beta-adrenergic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

A single fixation protocol for proteome-wide immunofluorescence localization studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Recommendations for Improved Standardization of Immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04184.X

10.1111/J.1365-2559.2012.04184.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference